# Clinical Study of Pulp Mesenchymal Stem Cells in the Treatment of Primary Mild to Moderate Knee Osteoarthritis

> **NCT04130100** · EARLY_PHASE1 · UNKNOWN · sponsor: **CAR-T (Shanghai) Biotechnology Co., Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **BIOLOGICAL:** Low Dose of Mesenchymal stem cell
- **BIOLOGICAL:** High Dose of Mesenchymal stem cell
- **DRUG:** Sodium Hyaluronate

## Key facts

- **NCT ID:** NCT04130100
- **Lead sponsor:** CAR-T (Shanghai) Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-04
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04130100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04130100, "Clinical Study of Pulp Mesenchymal Stem Cells in the Treatment of Primary Mild to Moderate Knee Osteoarthritis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04130100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*